Review Article

Mass Spectrometry-Based Proteomic Study Makes High-Density Lipoprotein a Biomarker for Atherosclerotic Vascular Disease

Table 1

Selected studies of MS-based HDL proteomics.

DiseaseStudy populationQuantitative strategyMS approachValidationMajor findings

CAD with PTCA [78]CAD () 16O/18O and iTRAQ labeling, IEF and SCX seperationNano-LC- MS/MSNoneProtective properties of HDL might be impaired after PTCA

ACS [98]ACS (), healthy ()2D-DIGEMALDI-TOF-TOFELISA
Western blot
Functional HDL subfractions shifted to dysfunctional HDL subfractions during ACS

CAD [99]CAD (), ACS (), and healthy ()1D-PAGE and label-free quantification (peptide index)Nano-LC-MS/MSELISA
IHC
Western blot
A reduced clusterin and increased apolipoprotein C-III content of HDL in CAD and ACS as mechanisms leading to altered effects on endothelial apoptosis

Hemodialysis (HD) [79]HD (), healthy ()iTRAQ with IEF fractionationLC-MALDI-TOFELISAIncrease of apoCII/apoCIII and the decrease of serotransferrin in HDL of HD patients

CAD
ACS [80]
Healthy (), CAD (), and ACS ()Label-free quantification (spectral counts and emPAI)Nano-LC-MS/MSImmunoblot or ELISAIncreased abundance of SAA, C3, and other inflammatory proteins in HDL from ACS patients suggests that HDL reflects a shift to an inflammatory profile

AMI [82]AMI (),
FH (), and
healthy ()
2D-PAGEMALDI-TOFELISA
Western blot
TTR values are reduced in patients with high cardiovascular risk

Uremia [81]ESRD (), healthy (), and CKD ()1D-PAGE, label-free method with peptide indexNano-LC-MS/MSELISA
Western blot
SAA in ESRD-HDL can promote inflammatory cytokine production

CAD [8]CAD (), healthy ()MALDI-TOF peptide profilingMALDI-TOF-TOFMALDI-TOFDeveloped a MALDI-TOF pattern containing peptides from apoA-I (oxidation at Met (112)), apoC-III (upregulated), lipoprotein(a) (upregulated), and apoC-I (downregulated) to classify CAD and control subjects

PTCA: percutaneous transluminal coronary angioplasty, ACS: acute coronary syndromes, AMI: acute myocardial infarction, CVD: cardiovascular disease, CAD: coronary artery disease, EBI: European Bioinformatic Institute, FH: familiar hypercholesterolemia, MI: myocardial infarction, MS: mass spectrometer, UC: ultracentrifugation, RA: rheumatoid arthritis, HD: hemodialysis.